This is a profile image of Jeffrey Algazy

Jeffrey Algazy

Senior PartnerNew Jersey

Advises healthcare clients on commercial performance, medical and R&D transformation, and corporate strategy with a primary focus on bio-pharma and healthcare products manufacturers

Jeffrey is a senior partner in the firm’s New Jersey office and a leader within our Life Sciences Practice. He is primarily focused on the pharmaceuticals and medical products division, and also heads our R&D efforts across this sector. Much of his work over the nearly 20 years at the firm has focused on brand and therapeutic area strategies, including late-stage development, marketing, medical affairs, and product launch. In addition, he works with companies on corporate strategy including integration and due diligence.

Jeff leads our global work on pharmaceuticals and medical products related to metabolism, and has worked on diabetes and obesity issues across pharmaceuticals, medical products, healthcare systems, and consumer. He has worked with clients in North America, Europe, Asia, and the Middle East on a variety of issues regarding the diabetes epidemic. Jeff is also one of the firm's leading experts in rare diseases with work focusing on commercialization, patient finding, and patient services. Jeff is a physician by training and was board certified in internal medicine. After completing his medical training he ran a diabetes clinic in Los Angeles prior to joining the firm.


Provisioning the front lines in the pandemic,” McKinsey & Company, May 2020

Published work

A vision for medical affairs 2030: Five priorities for patient impact,” McKinsey & Company, October 2023

Vision 2028: How China could impact the global biopharma industry,” McKinsey & Company, August 2022


UCLA Robert Wood Johnson Foundation
Clinical scholar

Hospital of the University of Pennsylvania
Internal medicine resident


Yale School of Medicine

University of Pennsylvania
BA, biology